Investigators evaluated speech-based screening for Generalized Anxiety Disorder symptoms using a dataset of 1,788 adults recruited in Botswana, Ghana, Nigeria, and Tanzania. The team defined elevated symptoms by GAD-7 questionnaire scores ≥ 5, so labels derive from self-report rather than diagnostic interview. Speech was collected remotely and limited to neutral read tasks; the authors did not report using spontaneous conversational speech in this dataset. Acoustic feature extraction relied on the extended Geneva Minimalistic Acoustic Parameter Set. Context-augmented models appended participant age, self-reported health, and sex where relevant. The study procedures and approvals were reported as obtained from institutional review boards at the participating universities.
The dataset composition — number of participants per country or per sex strata — was not specified in the abstract. Investigators noted that voice recordings are treated as identifiable biometric data and therefore cannot be publicly shared; they offered additional supporting data by request from the corresponding author.
Nine classification algorithms were assessed across nine experimental scenarios defined by speech-task configuration (short sentence, long passage, or combined) and sex stratification, using participant-separated, repeated nested cross-validation. Feature selection was applied in some runs, but the authors found no consistent benefit from selection across all scenarios. For acoustic-only inputs, the highest reported mean AUCROC with feature selection was 0.594. When models incorporated contextual variables (age, self-reported health, and sex where applicable), the peak mean AUCROC rose to 0.699; that top value occurred in the female-only combined-task scenario, according to the abstract.
Performance varied by scenario; investigators reported scenario-dependent differences rather than uniformly strong discrimination. The study team emphasized that neutral read speech acoustics alone delivered limited discrimination for elevated anxiety symptoms, and that adding brief participant context improved model performance but did not produce clinical-grade accuracy by the metrics provided.
The authors used Shapley additive explanations (SHAP) to probe model interpretability. SHAP identified fundamental frequency descriptors as prominent predictors among acoustic features. In context-augmented models, self-reported health status and participant age emerged as leading predictors. Investigators reported these variable-level attributions rather than causal claims; the analysis indicates which features carried weight during classification under the evaluated models.
The abstract did not list specific fundamental frequency metrics (for example: mean F0, F0 variance) or the exact magnitude of SHAP values. It also did not report how acoustic predictors differed between male and female strata beyond the improved discrimination observed in the female combined-task scenario.
Secondary analyses used regression models to estimate continuous GAD-7 symptom severity from the same speech and context features, but investigators reported poor performance. The authors concluded that neutral speech acoustics did not reliably predict continuous symptom scores in this sample. That negative finding frames a practical boundary: screening classification showed modest improvement with context, yet estimating symptom burden quantitatively remains unsupported by the presented models.
Data access and sharing were explicitly constrained. Voice recordings were classified as identifiable biometric data and are not publicly available; the authors stated that additional data supporting their results can be requested from the corresponding author. Funding disclosures included support from the Spartan Tetrad Program and a grant from the National Research Foundation of South Africa. The authors declared no competing interests and reported institutional ethics approvals at the listed universities.
Study limitations reported in the abstract include the modest discrimination from neutral speech acoustics and the need for external validation. The abstract did not provide details on participant demographics by country, the balance of positive versus negative labels, or the exact classifiers and hyperparameters evaluated; those methodological specifics were not reported in the abstract and would require consulting the full manuscript or supplementary materials. The last actionable item the authors stated was the need for external validation of these models before any further consideration of clinical deployment.